Routine diagnostic analyses of mutations in cell-free DNA in patients with metastatic prostate cancer are now possible for the first time in Sweden. The test has been developed by researchers at Karolinska Institutet, and Karolinska University Hospital is now offering the analysis to hospitals around the Nordic region, giving more patients with certain gene mutations access to the cancer treatment they need.
New test launched for men with metastatic prostate cancer
Routine diagnostic analyses of mutations in cell-free DNA in patients with metastatic prostate cancer are now possible for the first time in Sweden. The test has been developed by researchers at Karolinska Institutet, and Karolinska University Hospital is now offering the analysis to hospitals around the Nordic region, giving more patients with certain gene mutations access to the cancer treatment they need.